Page 109 - 202008
P. 109

nal insufficiency following trastuzumab treatment for  breast cancer patients:two case reports and a literature re-
             breast cancer in pregnancy:case report und review of the  view[J]. S Afr Med J,1997,87(11):1538-1539.
             current literature[J]. Breast Care:Basel,2011,6(6):  [32]  ILLIDGE TM,HUSSEY M,GODDEN CW. Malignant
             475-478.                                           hypercalcaemia in pregnancy and antenatal administration
        [17]  TOBE M,STEPHEN C,VASANTHA K,et al. Breast can-    of intravenous pamidronate[J]. Clin Oncol:R Coll Radiol,
             cer in pregnancy:case report[J]. Pan Afr Med J,2010.  1996,8(4):257-258.
             DOI:10.4314/pamj.v521.56195.                  [33]  BARNI S,ARDIZZOIA A,ZANETTA G,et al. Weekly
        [18]  SZEKELY B,LANGMAR Z,SOMLAI K,et al. Treat-        doxorubicin chemotherapy for breast cancer in pregnancy:
             ment of pregnancy associated breast cancer[J]. Orv Hetil,  a case report[J]. Tumori,1992,78(5):349-350.
             2010,151(32):1299-1303.                       [34]  LELLÉ RJ,BEISLER G,UNLU C. Effect of pregnancy
        [19]  LOGUE K. Pregnancy-associated breast cancer[J]. Clin J  on metastasizing breast cancer:a case report[J]. Z Geburt-
             Oncol Nurs,2009,13(1):25-27.                       shilfe Perinatol,1986,190(5):229-231.
        [20]  DIAMOND JR,FINLAYSON CA,THIENELT C,et al.    [35]  YILDIRIM N,BAHCECI A. Use of pertuzumab and
             Early-stage BRCA2-linked breast cancer diagnosed in the  trastuzumab during pregnancy[J]. Anticancer Drugs,
             first trimester of pregnancy associated with a hypercoagu-  2018,29(8):810-813.
             lable state[J]. Oncology:Williston Park,2009,23(9):  [36]  NARGOTRA N,KALITA D. Pregnancy associated breast
             784-791.                                           cancer:awareness is the key to diagnosis:a case report[J].
        [21]  WITZEL ID,MULLER V,HARPS E,et al. Trastuzumab     J Clin Diagn Res,2015,9(11):9-11.
             in pregnancy associated with poor fetal outcome[J]. Ann  [37]  YAO C,XIA H,WANG Y,et al. Long-term treatment af-
             Oncol,2008,19(1):191-192.                          ter preoperative high-dose chemotherapy in a lactating
        [22]  SKRABLIN S,BANOVIC V,MATKOVIC V. Adriamy-         breast cancer patient[J]. Cell Biochem Biophys,2014,69
             cin and cyclophosphamide chemotherapy in advanced  (1):61-64.
             breast cancer in pregnancy[J]. Eur J Obstet Gynecol Re-  [38]  ALIPOUR S,SEIFOLLAHI A,ANBIAEE R. Lactating
             prod Biol,2007,133(2):251-252.                     breast abscess:a rare presentation of adenosquamous
        [23]  SEKAR R,STONE PR. Trastuzumab use for metastatic  breast carcinoma[J]. Singapore Med J,2013,54(12):
             breast cancer in pregnancy[J]. Obstet Gynecol,2007,110  247-249.
            (2 Pt 2):507-510.                              [39]  ROKUTANDA N,IINO Y,YOKOE T,et al. Primary
        [24]  MARTINEZ-RAMOS D,FERRARIS C,GRECO M,et            squamous cell carcinoma of the breast during lactation:a
             al. Breast carcinoma during pregnancy[J]. Cir Esp,2007,  case report[J]. Jpn J Clin Oncol,2000,30(6):279-282.
             82(5):305-307.                                [40]  LI T,MELLO-THOMS C,BRENNAN PC. Descriptive
        [25]  BODNER-ADLER B,BODNER K,ZEISLER H. Breast         epidemiology of breast cancer in China:incidence,mortal-
             cancer diagnosed during pregnancy[J]. Anticancer Res,  ity,survival and prevalence[J]. Breast Cancer Res Treat,
             2007,27(3b):1705-1707.                             2016,159(3):395-406.
        [26]  KERR JR. Neonatal effects of breast cancer chemotherapy  [41]  LANGER A,MOHALLEM M,STEVENS D,et al. A sin-
             administered during pregnancy[J]. Pharmacotherapy,2005,  gle-institution study of 117 pregnancy-associated breast
             25(3):438-441.                                     cancers(PABC):presentation,imaging,clinicopathologi-
        [27]  KATZ MS,SCHAPIRA L,HARISINGHANI MG,et al.         cal data and outcome[J]. Diagn Interv Imaging,2014,95
             Palpable right breast mass in a pregnant woman[J]. Nat  (4):435-441.
             Clin Pract Oncol,2005,2(4):218-221.           [42]  OPDAHL S,ALSAKER MD,JANSZKY I,et al. Joint ef-
        [28]  ISHIKAWA T,HAMAGUCHI Y,MOMIYAMA N,et al.          fects of nulliparity and other breast cancer risk factors[J].
             Pregnancy-associated breast cancer with multiple metasta-  Br J Cancer,2011,105(5):731-736.
             ses[J]. Eur J Surg,2002,168(7):428-430.       [43]  DURRANI S,AKBAR S,HEENA H. Breast cancer dur-
        [29]  DE SANTIS M,LUCCHESE A,DE CAROLIS S,et al.        ing pregnancy[J]. Cureus,2018. DOI:10.7759/cureus.2941:
             Metastatic breast cancer in pregnancy:first case of chemo-  e2941.
             therapy with docetaxel[J]. Eur J Cancer Care:Engl,2000,  [44]  TRAVIS RC,KEY TJ. Oestrogen exposure and breast can-
             9(4):235-237.                                      cer risk[J]. Breast Cancer Res,2003. DOI:10.1186/bcr628.
        [30]  ZANCONATI F,ZANELLA M,FALCONIERI G,et al.    [45]  JOHANSSON ALV,ANDERSSON TM,HSIEH CC,et
             Gestational squamous cell carcinoma of the breast:an un-  al. Tumor characteristics and prognosis in women with
             usual mammary tumor associated with aggressive clinical  pregnancy-associated breast cancer[J]. Int J Cancer,2018,
             course[J]. Pathol Res Pract,1997,193(11):783-787.  142(7):1343-1354.
        [31]  MURRAY EM,WERNER ID. Pregnancy and abortion in  [46]  BORGES VF,SCHEDIN PJ. Pregnancy-associated breast


        中国药房    2020年第31卷第8期                                              China Pharmacy 2020 Vol. 31 No. 8  ·995  ·
   104   105   106   107   108   109   110   111   112   113   114